Sign up to save your podcasts
Or
Share Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma
40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.
View all episodes
By Moira Gunn
4.1
2929 ratings
40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.
More shows like BioTech Nation ... with Dr. Moira Gunn
View all
TED Radio Hour
21,967 Listeners
Radiolab
43,944 Listeners
Freakonomics Radio
32,101 Listeners
Planet Money
30,693 Listeners
Hidden Brain
43,701 Listeners
Entrepreneurial Thought Leaders (ETL)
708 Listeners
Science Friday
6,386 Listeners
How I Built This with Guy Raz
30,226 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Readout Loud
323 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,957 Listeners
BioCentury This Week
33 Listeners
Biotech Hangout
19 Listeners
Ground Truths
48 Listeners
The Future of Everything
139 Listeners